echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Cognitively driven impairment of daily living skills as a predictor of Parkinson's disease dementia: a longitudinal cohort study

    Neurology: Cognitively driven impairment of daily living skills as a predictor of Parkinson's disease dementia: a longitudinal cohort study

    • Last Update: 2022-10-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    One-third of people with Parkinson's disease (PDMCI) with mild cognitive impairment (PDMCI) transition to dementia within a few years
    .
    Markers with high prognostic value for dementia transformation are needed
    .
    Loss of daily functioning, mainly due to cognitive dysfunction, is the core criterion for diagnosing dementia in Parkinson's disease, and more complex instrumental activities of daily living (IADL) dysfunction begins to appear in the prodromal phase
    .
    This study assesses phenotypes associated with cognitive IADL impairment and their predictive value
    for defining people at high risk of Parkinson's disease dementia.

    In addition to genetic and cerebrospinal fluid biomarkers, an observational longitudinal study was conducted, using cognitive and clinical scores
    .
    The Functional Activity Questionnaire (FAQ) quotient (cut-off ≥1), which indicates more cognitive impairment than exercise-driven impairment of independent living, defines the state of cognitive independent living impairment at
    baseline.
    Risk ratios (HR) were used to compare the effects of
    baseline classification on dementia transformation.

    Of the 268 patients with PD assessed at baseline, 108 (40.
    3%) had PD-MCI
    .
    After an average of 3.
    78±0.
    84 years, 164 patients (61.
    2%) were reevaluated
    .
    At follow-up, 93 (56.
    7%) patients had no cognitive impairment, 54 (32.
    9%) met PD-MCI criteria, and 17 (10.
    4%) developed dementia
    .
    The heart rate of patients with dementia with baseline cognitive impairment (n=37) was significantly higher than that of PD-MCI patients, but the highest in patients with these two indicators (HR=12.
    01, 95%-CI4.
    47~32.
    22, P<0.
    001).

    In the follow-up sample, nearly half (n=10, 47.
    6%) of patients with cognitive IADL impairment and baseline classification of PDMCI switched to dementia
    .
    During the study period, baseline status of cognitive IADL impairment was associated
    with higher non-exercise load, poorer cognitive performance, and more severe IADL progression.

    It is critical
    to distinguish between cognitive and motor aspects on ADL function in patients with Parkinson's disease and to monitor cognitive ADL impairment during the prodromal phase of dementia.
    Patients with PD-MCI and cognitive IADL disorders may be valuable target groups
    for clinical trials aimed at slowing the progression of dementia.

    Source: Becker S, Bode M, Brockmann K, et al.
    Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study [published online].
    ahead of print, 2022 Sep 2].
    Neurology.
    2022; 10.
    1212/WNL.
    0000000000201201.
    doi:10.
    1212/WNL.
    0000000000201201

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.